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Familial Skewed X Inactivation and X-Linked
Mutations: Unbalanced X Inactivation is a Powerful
Means to Ascertain X-Linked Genes That Affect Cell
Proliferation
To the Editor:
We read with great interest the article by Pegoraro et al.
(1997) in which they report familial skewed X inacti-
vation associated with a submicroscopic deletion at
Xq28. This deletion, which spans ∼800 kb near the F8C
locus, is transmitted in the expected X-linked fashion
through females, but no males have the deletion. Al-
though we agree that the skewed X-inactivation pattern
in this family is attributable to the region around or
included in the deletion, we disagree with their inter-
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pretation of these results and with some assertions that
may lead to confusion about the underlying basis for
skewed X inactivation in this family.
The authors suggest that the simplest interpretation
of their data is that this disorder behaves like an X dom-
inant with lethality in the male fetus. All the evidence
supports this hypothesis: The Xq28 deletion is lethal
when present in hemizygous males and confers a pro-
liferative disadvantage to cells of heterozygous females
in whom the deleted chromosome is active, which ex-
plains why these females are clinically normal.
However, Pegoraro et al. (1997) considered the hy-
pothesis of an X-dominant disorder with male lethality
inconsistent with their data on the basis that the relevant
locus cannot be a genetic or cell lethal, because, if so,
affected males would die soon after fertilization. In fact,
the time at which a male embryo carrying the deletion
would become inviable, or at which the population of
mutant cells in the female would be eliminated, depends
on the nature of the mutant gene product—when it is
needed, in which cells it is expressed, and how detri-
mental (or advantageous) it is in the presence of wild-
type cells in the mosaic population. Clearly, a male with
this small deletion might not be aborted before the preg-
nancy is recognizable; some males with macroscopic de-
letions of the X chromosome can survive until late ges-
tation or term (Rosenberg et al. 1987; Cremers et al.
1988).
This family resembles those in which selection has
been shown to underlie X inactivation. The familial
skewing seen with mutations at the incontinentia pig-
menti (IP) locus, in cytogenetically normal females, is
also associated with recurrent abortion (Migeon et al.
1989; Parrish et al. 1996). However, IP heterozygotes
do not eliminate their mutant population of cells as com-
pletely as do the heterozygotes in this family, and hence
some IP heterozygotes may be clinically abnormal. Large
differences in the growth of normal and abnormal cells
can result in early loss of disfavored cells, whereas more
subtle differences account for progressive loss during the
lifetime of the heterozygote (Migeon et al. 1981, 1988).
The familial skewed X inactivation associated with ad-
renoleukodystrophy was also mapped to Xq28, by tight
linkage with the G6PD locus (Migeon et al. 1981), and
was shown to be attributable to a proliferative advan-
tage of the mutant gene.
Pegoraro et al. (1997) suggest two alternative novel
hypotheses to explain their findings: (1) the deleted re-
gion in Xq28 is directly involved in the primary mech-
anisms of X inactivation; or (2) the region is directly
responsible for skewing. In either case, the observed
skewing is attributed to a gene in Xq28 that determines
the choice of X chromosome to inactivate or the ability
of an X to inactivate. As Pegoraro et al. (1997) note,
there is no evidence in either mouse or human to support
the existence of a such a gene within the deletion at
Xq28. In addition, there is uncited evidence (discussed
below) that argues against the existence of such a hy-
pothetical locus in Xq28.
There may be multiple trans-acting factors involved
in the initiation and maintenance of X inactivation. Ob-
servations of triploid embryos suggest that these are
likely to reside on autosomes (discussed by Jacobs and
Migeon 1989). There is no convincing evidence that fac-
tors responsible for cis inactivation lie outside the X
chromosome–inactivation center (XIC) at Xq13.2. Stud-
ies of chromosomal deletions and translocations leading
to deletions indicate that this segment is the site of the
XIC (Therman et al. 1979; Mattei et al. 1981), and all
X-linked genes shown to have an effect on choice (Xce)
or on inactivation (XIST) lie within this region. Evidence
that other regions of the X are unlikely to be relevant
in the choice of X to inactivate comes from recent studies
of the murine XIC region transfected into male embry-
onic stem cells, which indicate that the XIC region con-
tains all the genetic information needed for cis inacti-
vation of an X chromosome, including choice of inactive
X (Lee et al. 1996; Lee and Jaenisch 1997).
None of the reported families with skewed patterns
of X inactivation has been shown, convincingly, to in-
volve the mechanisms of X inactivation. Most of them
can be explained by mutations or cytogenetic deletions
that adversely affect the proliferation of one of the cell
populations produced by random X inactivation (re-
viewed in Belmont 1996). In light of this, it seems that
relatively few cases of familial unbalancedX inactivation
will be due to mutations causing primary nonrandom
inactivation. Although mutations affecting the process
of X inactivation are real possibilities, one expects that
those severe enough to interfere with X inactivation
would be embryonic lethals, because of the functional
X disomy. Mutations in the inactivation machinery that
are associated with normal phenotypes and two intact
X chromosomes are most likely to be the ones that in-
fluence only the choice of X to inactivate and therefore
would be at the XIST or an Xce-like locus or in other
constituents of the XIC. However, even linkage to the
XIC or with specific XIST alleles (Plenge et al. 1997) is
not sufficient evidence that skewing is in fact attributable
to these genes, because it could be due to a hitchhiker
effect, resulting from mutations in a close neighbor with
potential for cell selection.
We believe that familial skewing, which maps to the
X chromosome but is unlinked to the XIC, most likely
results from mutations that do not interfere with the
inactivation machinery but that affect the proliferation
of the cell populations produced following normal ran-
dom X inactivation. Females who manifest X-recessive
diseases provide a powerful means to detect unbalanced
X inactivation (Migeon 1993). The corollary is that
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skewed patterns of X inactivation, familial or not, pro-
vide a powerful means of ascertaining mutations that
influence cell proliferation.
BARBARA R. MIGEON AND CAMILLE HAISLEY-ROYSTER
Department of Pediatrics and
Center for Medical Genetics
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Reply to Migeon and Haisley-Royster
To the Editor:
We thank Drs. Migeon and Haisley-Royster (1998 [in
this issue]) for their interest in our research. We are,
however, a bit puzzled by their letter to the editor, since
they write that they disagree with the interpretation of
our results yet then restate what was already written in
our previously published article (Pegoraro et al. 1997 ).
The 50-member pedigree that we reported showed an
X-linked dominant disorder with male lethality. There
is no question of this fact, because we found a deletion
mutation of Xq28 associated with skewedX inactivation
and recurrent pregnancy loss (LOD  6.92). The dele-
tion included the factor VIII gene, yet there were no
males from 50 females with factor VIII deficiency, again
clearly proving that this family had an X-linked domi-
nant disorder with male lethality.
Drs. Migeon and Haisley-Royster appear to wish to
address two issues: (1) interpretation of the likely mech-
anisms that would cause X-inactivation skewing in the
females in this family; and (2) transcriptional timing of
the deleted gene or gene products in Xq28 and the ob-
served effect on miscarriage detection. There is very little
to disagree with in Drs. Migeon and Haisley-Royster’s
interpretation of our results; they suggest that a growth
disadvantage is probably playing a role, which is pre-
cisely what we stated in our discussion. We, too, feel
that growth disadvantage is the most likely mechanism
causing skewing of X-chromosome inactivation. How-
ever, in the absence of characterization of the causative
genes in Xq28, it seems unreasonable to dismiss the pos-
sibility that the gene(s) may actually be involved in the
process of X inactivation. This is the least likely mech-
anism, but it does not seem to warrant exclusion from
discussion.
The timing of transcription of the gene products in
Xq28 undoubtedly affects when the miscarriage occurs.
In fact, the issue of timing is central to the inferred ge-
